September 10, 2014  

CDU Obtains $15.5 Million Grant from NIH and NIMHD to Continue AXIS Program


LOS ANGELES, CA – Charles R. Drew University of Medicine and Science (CDU) has announced that it was chosen to continue its work with the National Institutes of Health’s (NIH) and the National Institute on Minority Health and Health Disparities’ (NIMHD) Accelerating eXcellence In Translational Science (AXIS) program.

“We were successful in obtaining $15.5M over five years funding with an outstanding score,” said Dr. Jay Vadgama, Principal Investigator of the grant. “I would like to express my most sincere gratitude and thanks to the entire AXIS Team that includes former and current members and the CDU leadership for this successful outcome. We are also very grateful to our partnership with NIMHD.”

AXIS is the integrated “home” for clinical and translational research. AXIS houses experienced leadership as well as a myriad of clinical, translational, community-partnered activities, well matched by the education, training, and technology resources and excellent research core services. In the next five years, CDU will continue building a research infrastructure that will promote multi- and interdisciplinary collaborations between CDU investigators and community partners targeting health disparities.

The vision of the University Research Enterprise is to be a leading player in the national effort to eliminate health disparities, specifically through AXIS in three areas of focus which disproportionally affect Service Planning Area (SPA) 6: Cancer, Cardio-metabolic Disease (CMD), and HIV/AIDS. AXIS proposes three programmatic goals that align with the vision of the University’s Research Enterprise:

Goal 1: To enhance the infrastructure capacity in translational research in the areas of Cancer, Cardio-metabolic, and HIV/AIDS. Although other areas of research at CDU will also be served, the focus will be to create expertise and research success in these three areas.

Goal 2: To integrate basic, clinical, and community-partnered translational research by fostering collaboration among disciplines, departments and schools at CDU, and collaboration with community leaders and investigators across other research institutions.

Goal 3: To facilitate professional development and best practices in mentored clinical and translational research training on minority health and health disparities.

Overall, these goals will also ensure that CDU continues to provide national leadership in reducing health disparities by increasing the quality and quantity of researchers from minority and underserved populations conducting disparities research.

For more information about the AXIS Program at CDU, please visit

Research reported in this publication was supported by the National Institute On Minority Health and Health Disparities of the National Institutes of Health under Award Number U54MD007598. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.



Isidra Person-Lynn,
Communications Specialist
323.563.5833 or 213.422.8707




About Charles R. Drew University of Medicine and Science
CDU is a private, nonprofit, nonsectarian, medical and health sciences institution. Located in the Watts-Willowbrook area of South Los Angeles, CDU has graduated more than 550 medical doctors, 2,700 post-graduate physicians, more than 1,200 physician assistants, 450 nurses and hundreds of other health professionals. CDU’s mission is to conduct education, research and clinical services in the context of community engagement to train health professionals who promote wellness, provide care with excellence and compassion, and transform the health of underserved communities. For more information, visit .


1731 East 120th Street, Los Angeles, CA 90059
p 323 563 4987  f 323 563 5987

A Private University with a Public Mission

Share |